BBC0403 is a selective BRD2 inhibitor. BBC0403 inhibits the progression of osteoarthritis pathogenesis in osteoarthritis-induced C57BL/6 male mice. TR-FRET and binding kinetics assays revealed that BBC0403 exhibited higher binding specificity for BRD2 compared to BRD3 and BRD4.
For research use only. We do not sell to patients.
| Name | BBC0403 |
|---|---|
| Iupac Chemical Name | 2-(3,5-dimethyl-4-(oxetan-3-yloxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one |
| Synonyms | BBC0403; BBC-0403; BBC 0403; |
| Molecular Formula | C21H22N2O5 |
| Molecular Weight | 382.41 |
| Smile | O=C1NC(C2=CC(C)=C(OC3COC3)C(C)=C2)=NC4=C1C(OC)=CC(OC)=C4 |
| InChiKey | AGBJJHZARZYKNH-UHFFFAOYSA-N |
| InChi | InChI=1S/C21H22N2O5/c1-11-5-13(6-12(2)19(11)28-15-9-27-10-15)20-22-16-7-14(25-3)8-17(26-4)18(16)21(24)23-20/h5-8,15H,9-10H2,1-4H3,(H,22,23,24) |
| CAS Number | 2644662-83-7 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid |
|---|---|
| Purity | 98% Min. |
| Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Lee H, Nam J, Jang H, Park YS, Son MH, Lee IH, Eyun SI, Yang JH, Jeon J, Yang S. BRD2-specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis-induced C57BL/6 male mice. Br J Pharmacol. 2024 Aug;181(15):2528-2544. doi: 10.1111/bph.16359. Epub 2024 Apr 10. PMID: 38600628.